Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?
Wiersbitzky, S.
Kinderarztliche Praxis 61(3): 120-121
1993
ISSN/ISBN: 0023-1495 PMID: 8392122 Document Number: 406072
Document emailed within 1 workday
Related Documents
Lim, F.Seng.; Han, H-Htay.; Jacquet, J-Marie.; Bock, H.L. 2007: Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine Annals of the Academy of Medicine Singapore 36(10): 801-806Dane, D.S.; Dick, G.W.A.; Connolly, J.H.; Fisher, O.D.; McKeown, F.; Briggs, M.; Nelson, R.; Wilson, D. 1957: Vaccination Against Poliomyelitis with Live Virus Vaccines: 1. a Trial of TN Type Ii Vaccine. 2. a Trial of SM Type i Attenuated Poliomyelitis Virus Vaccine. 3. the Evaluation of TN and SM Virus Vaccines BMJ 1(5010): 59-74
Vivell, O. 1973: Oral vaccination against poliomyelitis Deutsche Medizinische Wochenschrift 98(20): 1049
Choudhury, D.S.; Nossik, N.N.; Bindu; Vijayan, P.; Raghavan, N.G.; Paul, S.S. 1973: Poliomyelitis vaccination of infants: preimmunization status and seroconversion Bulletin of the World Health Organization 48(2): 195-198
Hara, M. 1990: Serodiagnosis of poliomyelitis and prevention using an oral vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 348-351
John, T.J. 1984: Immune response of neonates to oral poliomyelitis vaccine British Medical Journal 289(6449): 881
Prevots, D.R.; Strebel, P.M. 1997: Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine Pediatric Annals 26(6): 378-383
Dong, D.X.; Hu, X.M.; Liu, W.J.; Li, J.S.; Jin, Y.C.; Tan, S.G.; Chen, T.Q.; Fu, J.Z.; Niu, B.Y.; Yu, H.M. 1986: Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin) Bulletin of the World Health Organization 64(6): 853-860
Thilo, W.; Hempel, H.C.; Grimm, J.; Hayduk, J.; Starke, G. 1970: Inactivated oral Sh. sonnei vaccine. II. Formation and determination of humoral agglutinins following oral vaccination Das Deutsche Gesundheitswesen 25(6): 261-264
Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants Journal of Infectious Diseases 208(4): 672-678
Ali, M.; Emch, M.; Yunus, M.; Sack, D.; Lopez, A.L.; Holmgren, J.; Clemens, J. 2008: Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission Pediatric Infectious Disease Journal 27(1): 33-37
Szczepski, O.; Wlodarczak, K.; Walczak, M.; Walter, Z.; Klauziński, R. 1970: Immunoglobulin level in the saliva of children with poliomyelitis and healthy children following oral vaccination with live attenuatea strain of type 2 and 3 poliovirus Polski Tygodnik Lekarski 25(8): 281-283
Lehmann, H.G.; Engelhardt, H.; Freudenstein, H.; Hennessen, W.; Quast, U.; Widmark, R.M. 1979: BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen Developments in Biological Standardization 43: 133-136
Guglielmetti, P.; Bianchi Bandinelli, M.L.; Bartoloni, A.; Gamboa, H.; Roselli, M.; Valensin, P.E. 1994: Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia) Journal of Tropical Medicine and Hygiene 97(4): 231-235
Kintu, K.; Andrew, P.; Musoke, P.; Richardson, P.; Asiimwe-Kateera, B.; Nakyanzi, T.; Wang, L.; Fowler, M.G.; Emel, L.; Ou, S.-S.; Baglyos, L.; Gurunathan, S.; Zwerski, S.; Jackson, J.B.; Guay, L. 2013: Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa Journal of Acquired Immune Deficiency Syndromes 63(1): 1-8
Khatib, A.M.; Ali, M.; von Seidlein, L.; Kim, D.R.; Hashim, R.; Reyburn, R.; Ley, B.; Thriemer, K.; Enwere, G.; Hutubessy, R.; Aguado, M.T.; Kieny, M.-P.; Lopez, A.L.; Wierzba, T.F.; Ali, S.M.; Saleh, A.A.; Mukhopadhyay, A.K.; Clemens, J.; Jiddawi, M.S.; Deen, J. 2012: Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study LANCET. Infectious Diseases 12(11): 837-844
Kar, S.K.; Sah, B.; Patnaik, B.; Kim, Y.H.; Kerketta, A.S.; Shin, S.; Rath, S.B.; Ali, M.; Mogasale, V.; Khuntia, H.K.; Bhattachan, A.; You, Y.A.; Puri, M.K.; Lopez, A.L.; Maskery, B.; Nair, G.B.; Clemens, J.D.; Wierzba, T.F. 2014: Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model Plos Neglected Tropical Diseases 8(2): E2629
Zetterström, R. 2007: Merck's oral rotavirus vaccine RotaTeq suspected to cause invagination in infants Lakartidningen 104(9): 646
Haque, R.; Snider, C.; Liu, Y.; Ma, J.Z.; Liu, L.; Nayak, U.; Mychaleckyj, J.C.; Korpe, P.; Mondal, D.; Kabir, M.; Alam, M.; Pallansch, M.; Oberste, M.S.; Weldon, W.; Kirkpatrick, B.D.; Petri, W.A. 2014: Oral polio vaccine response in breast fed infants with malnutrition and diarrhea Vaccine 32(4): 478-482
Mayr, A. 2001: Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine Berliner und Munchener Tierarztliche Wochenschrift 114(5-6): 184-187